Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagdish Agrawal, a promoter of Ishita Drugs & Industries Ltd, purchased 161 equity shares of Rs. 10 each through the open market on September 3, 2025. His holding in the company rose marginally from 128,972 shares (4.31%) to 129,133 shares (4.32%) of the total share capital. The disclosure was filed under SEBI's Takeover Regulations to keep the stock exchange informed of the small acquisition. The total equity share capital of the company remains unchanged at Rs. 2,99,03,000 (29,90,300 shares). The acquisition is a routine open-market purchase by a promoter with no material change in ownership.
The acquisition is negligible in size (0.01% increase) and unlikely to have any meaningful impact on the stock price or shareholder value. It signals continued promoter confidence but does not change the controlling structure of the company.